Nanoemulsion vs Nanoliposome vs Nanomicelle: Comparing Carrier Architectures for Cosmeceutical Delivery

A technical comparison of the three nano-carrier architectures integrated in NanoBase™ - their structural differences, encapsulation capabilities, and why combining all three in a single platform outperforms any individual carrier system.

DOI Reference: 10.5281/zenodo.18616576

Three Carrier Architectures, Three Distinct Mechanisms

The nano-delivery landscape in cosmeceuticals is dominated by three carrier types: nanoemulsions, nanoliposomes, and nanomicelles. Each architecture exploits different self-assembly physics, encapsulates different active profiles, and interacts with the stratum corneum through distinct mechanisms. Most commercial platforms use one carrier type exclusively. NanoBase™ integrates all three into a co-stable tri-domain system - a fundamental architectural departure that requires understanding each domain's independent contribution.

Nanoemulsion Architecture: Oil-Continuous Lipophilic Transport

Nanoemulsions are thermodynamically metastable dispersions of oil droplets (dispersed phase) in an aqueous continuous phase, stabilized by surfactant films at the oil-water interface. In the NanoBase™ system, the nanoemulsion domain operates in the 150-195 nm range with droplet cores composed of medium-chain triglycerides (caprylic/capric triglyceride, INCI: Caprylic/Capric Triglyceride) or squalane (INCI: Squalane). The surfactant architecture employs polysorbate 80 (INCI: Polysorbate 80) as primary emulsifier with lecithin (INCI: Phosphatidylcholine) as co-surfactant.

Encapsulation strength: Lipophilic actives with log P greater than 3 - retinol (INCI: Retinol, log P ~6.3), tocopherol (INCI: Tocopherol, log P ~12.2), coenzyme Q10 (INCI: Ubiquinone, log P ~19.4). The oil core provides high loading capacity (typically 5-15% w/w active) with sustained release kinetics governed by oil-water partition coefficient. Stratum corneum interaction: hydrophobic compatibility with intercellular lipid matrix enables direct carrier-to-lamellae transfer of lipophilic cargo without requiring carrier disassembly.

Nanoliposome Architecture: Biomimetic Bilayer Vesicles

Nanoliposomes are closed bilayer vesicles self-assembled from phospholipids (primarily phosphatidylcholine, INCI: Hydrogenated Lecithin) and cholesterol (INCI: Cholesterol) in aqueous media. The NanoBase™ nanoliposomal domain produces vesicles in the 125-170 nm range with unilamellar or oligolamellar structure. The bilayer membrane encapsulates amphiphilic actives within its hydrophobic core while the aqueous interior compartment can carry hydrophilic molecules.

Encapsulation strength: Amphiphilic actives with intermediate log P (1-3) - niacinamide (INCI: Niacinamide, log P ~-0.37, carried in aqueous core), ceramide NP (INCI: Ceramide NP, log P ~15, incorporated in bilayer membrane), ascorbyl palmitate (INCI: Ascorbyl Palmitate, log P ~3.8, bilayer-associated). The dual-compartment structure enables simultaneous carriage of both hydrophilic and lipophilic species within a single carrier. Stratum corneum interaction: phospholipid bilayer composition mimics native SC lipid lamellae, enabling membrane fusion - the liposome integrates directly into the intercellular lipid structure, releasing cargo at the point of fusion.

Nanomicelle Architecture: Surfactant-Stabilized Hydrophilic Cores

Nanomicelles form spontaneously above the critical micelle concentration (CMC) of surfactant molecules in aqueous solution. In NanoBase™, the nanomicellar domain employs polyethylene glycol-modified surfactants (PEG-40 hydrogenated castor oil, INCI: PEG-40 Hydrogenated Castor Oil) to produce micelles in the 130-165 nm range. The micelle core is hydrophilic, surrounded by a hydrophobic surfactant corona that interfaces with aqueous environments.

Encapsulation strength: Hydrophilic actives with log P less than 1 - hyaluronic acid oligomers (INCI: Sodium Hyaluronate, MW 5-10 kDa fragments), peptides (palmitoyl tripeptide-1, INCI: Palmitoyl Tripeptide-1), and water-soluble antioxidants (L-ascorbic acid, INCI: Ascorbic Acid, log P ~-1.8). Stratum corneum interaction: PEG corona creates transient hydration channels in the intercellular lipid matrix, enabling aqueous-phase cargo to traverse normally hydrophobic barrier regions. This mechanism is unavailable to both nanoemulsions and nanoliposomes.

Why Single-Carrier Platforms Cannot Match Tri-Domain Performance

Each carrier architecture has fundamental encapsulation limitations. Loading a hydrophilic peptide into a nanoemulsion results in poor encapsulation efficiency (typically less than 10%) and burst release at the skin surface. Loading a lipophilic active into a nanomicellar core results in thermodynamic instability as the active partitions toward the surfactant corona. Even nanoliposomes - the most versatile single carrier - cannot simultaneously optimize bilayer composition for both highly lipophilic (log P greater than 10) and highly hydrophilic (log P less than -1) actives without compromising membrane integrity.

NanoBase™ tri-domain architecture eliminates these compromises by maintaining three independent carrier populations in a single formulation matrix. DLS analysis (DOI: 10.5281/zenodo.18616576) confirms that each domain maintains its characteristic size distribution with overall PDI below 0.20 - demonstrating that the three populations coexist without cross-domain contamination, carrier fusion, or Ostwald ripening between domains.

Formulation Implications for Multi-Active Products

Modern cosmeceutical formulations routinely combine 5-15 active ingredients spanning the full log P spectrum. In legacy formulation approaches, this requires empirical compatibility testing of each active pair - an exponentially scaling problem. With NanoBase™, each active is assigned to its physicochemically optimal carrier domain during formulation design, reducing the compatibility challenge to within-domain interactions only. Cross-domain stability is maintained by the self-assembly thermodynamics of each carrier type operating independently at its own CMC, phase inversion temperature, or bilayer closure concentration.

For brand partners developing multi-active serums, the practical outcome is faster formulation timelines, higher active loading efficiency, and batch-to-batch consistency verified by a single DLS measurement that characterizes all three carrier populations simultaneously.